Literature DB >> 2157548

Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

H Yamasaki1, E Okamoto, T Komatsu, Y Manabe, S Shinka.   

Abstract

The levels of a variety of immunological parameters were examined in 203 preoperative patients with hepatocellular carcinoma (HCC) at various stages (I-IV). The changes in the peripheral blood lymphocyte (PBL) count, the serum level of immunosuppressive acidic protein and the degree of the skin reaction to purified protein derivative were associated significantly with the stage of HCC progression. However, the percentages of lymphocyte subsets, mitogenic responsiveness of PBL and serum immunoglobulin concentration remained at the levels of stage I. Further study demonstrated that in patients undergoing hepatic artery ligation, there were statistically significant correlations between the PBL count, immunosuppressive acidic protein concentration and intensity of the skin reaction to purified protein derivative, assayed 1 month after surgery, and the prognosis. HCC-specific immunity was examined in 34 patients treated by hepatic resection or hepatic artery ligation using in vitro responses of PBL to HCC extracts (ATS test). This test was performed using culture medium containing added arginine. None of the PBL from the patients showed a positive response to allogeneic HCC extracts, but the PBL from 12 patients (9 hepatic resections, 3 hepatic artery ligations) were stimulated significantly (SI greater than or equal to 2.5) with autologous HCC extracts. In 7 of 9 hepatic resection patients who were positive in the ATS test, tumor recurrence was identified. Statistical analysis indicated that the ATS test result was significantly correlated with tumor recurrence in hepatic resection patients. Autologous-PBL-stimulating activities were isolated in a fraction at pH 8.3 and in fractions at pH 6.7-7.0 by chromatofocusing of the crude extract. Although identification of the HCC-specific antigen remains to be done, use of the above fractions may simplify the ATS test procedure and improve its sensitivity.

Entities:  

Mesh:

Year:  1990        PMID: 2157548     DOI: 10.1007/BF01742374

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Tumor-specific antigen solubilized by hypertonic potassium chloride.

Authors:  M S Meltzer; E J Leonard; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

2.  Lymphocyte stimulation by soluble human HL-A transplantation antigens.

Authors:  D C Viza; O Degani; J Dausset; D A Davies
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

3.  Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma.

Authors:  T Saibara; S Onishi; H Sakaeda; Y Yamamoto
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

4.  Antigen solubilized from human leukemia: lymphocyte stimulation.

Authors:  J U Gutterman; G Mavligit; K B McCredie; G P Bodey; E J Freireich; E M Hersh
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

5.  Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens.

Authors:  G M Mavligit; J U Gutterman; C M McBride; E M Hersh
Journal:  Natl Cancer Inst Monogr       Date:  1973-06

6.  Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

Authors:  K Tamura; Y Shibata; Y Matsuda; N Ishida
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

7.  Primary liver cancers in Japan.

Authors: 
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

8.  Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole.

Authors:  K Son; M Kew; A R Rabson
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

9.  Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.

Authors:  C Lee; S Chen; T Lin
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

10.  Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.

Authors:  W J Halliday; J W Halliday; C B Campbell; A E Maluish; L W Powell
Journal:  Br Med J       Date:  1974-05-18
View more
  1 in total

1.  Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection.

Authors:  Hiroaki Shiba; Yuichi Ishida; Shigeki Wakiyama; Tomonori Iida; Michinori Matsumoto; Taro Sakamoto; Ryusuke Ito; Takeshi Gocho; Kenei Furukawa; Yuki Fujiwara; Shoichi Hirohara; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.